Rep. Alexandria Ocasio-Cortez (D-NY), a member of the progressive “Squad,” allegedly breached federal election and House ethics regulations by improperly allocating approximately $19,000 in campaign funds last year for treatment from a therapist specializing in ketamine therapy, according to a striking new complaint.

The National Legal and Policy Center, a watchdog organization based in Washington, D.C., submitted a joint complaint on Friday to both the Federal Elections Commission and the Office of Congressional Conduct. The group is urging these agencies to investigate Ocasio-Cortez, her campaign committee, and its treasurer, Frank Llewellyn.

This complaint seeks to clarify whether the payments made to Dr. Brian Boyle of Boston were inaccurately recorded in official documents as expenses for “leadership training and consulting.”

The filing follows an exclusive report from the Post last week that exposed this questionable expenditure.

“There is reason to believe that AOC’s use of campaign funds for a psychiatrist who lacks credentials in ‘leadership training’ did not serve a ‘bona fide campaign or political purpose,’ but rather catered to personal psychiatric needs for AOC or her campaign staff,” stated Paul Kamenar, counsel for the group, in the complaint.

Federal law prohibits the use of congressional campaign funds for personal expenses. Violators may face fines, imprisonment for up to five years, and may be required to reimburse the misused funds from their personal finances.

The NLPC requested the commission “impose appropriate penalties and disciplinary sanctions against AOC.”

The group also asked the Office of Congressional Conduct, or OCC, to refer the matter to the House Ethics Committee, which unlike the OCC, can issue subpoenas to witnesses and impose disciplinary action against the socialist lawmaker.

---

Follow The Post’s live coverage of President Trump and national politics for the latest news and analysis

---

AOC has previously talked about her own mental health, claiming she was in therapy following the Jan. 6 Capitol riots, when she said lawmakers effectively “served in war.”

Boyle — the chief psychiatric officer at Stella, a chain of mental health clinics focusing on “novel” therapies popular with Hollywood and Wall Street – received four payments from the socialist pol’s campaign last year totaling $18,725.

The expenses were marked as “leadership training and consulting.”

However, it’s unclear what the sessions consisted of or who participated. Ocasio-Cortez’s campaign did not respond to requests for comment.

“AOC’s spending almost $19,000 in campaign funds for a shrink appears to violate both the FEC and House Ethics rules prohibiting use of such funds for personal purposes,”  Kamenar told The Post.

“While AOC has been in therapy in the past, she should spend her own money if she needs psychiatric treatment from Dr. Brian Boyle, whose specialty includes narcissistic personality disorder.”

Boyle, a Harvard-trained doctor, calls himself an “interventional psychiatrist” and specializes in unorthodox methods for treatment-resistant depression, PTSD and anxiety.

He’s also considered a “leading authority” on ketamine, the controversial horse tranquilizer given to “Friends” star Matthew Perry in the month leading up to his tragic death.

Boyle’s clinic also offers other treatments popular with the 1 Percent, like stellate ganglion block, an anesthetic injected into a nerve cluster in the neck to calm the body’s fight-or-flight response. Billionaires like Bob Parsons, who’s battled PTSD since returning from the Vietnam War, have raved about the treatment.

AOC herself is no stranger to touting the benefits of drugs for therapy.

The “Squad” rep, who campaigned to end the federal prohibition of marijuana in 2018, has three times proposed legislation to make it easier to study magic mushrooms and other psychedelics.

As a freshman congresswoman in 2019, she introduced an amendment to allow the feds to spend taxpayer money on studying the medical potential of psilocybin, ecstasy and other drugs to treat mental illnesses, calling the early research “promising.”

During a House Energy and Commerce subcommittee hearing Thursday, AOC argued that some so-called “Schedule I” drugs like LSD and ecstasy – which have a high potential for abuse but no currently accepted medical use – actually have some therapeutic value.